News

  • Oct 3, 2022

    Hiraki and Abe presented OTS-Assay-related research at the 81st Annual Meeting of the Japanese Cancer Association.

  • Sep 28, 2022

    Nishizuka gave a talk in a symposium "practice and research successful case reports" at the 42nd Japan Society for Molecular Tumor Marker Research.

  • Sep 28, 2022

    Great support voices are now up at the crowdfunding site. Click https://www.securite.jp/fund/detail/7523

  • Sep 25, 2022

    Our collaborator, Takeshi Iwaya, M.D., Ph.D. presented OTS-Assay at a luncheon seminar sponsored by LSI Medience/Finggal Link in the 76th The Japan Esophageal Society Annual Meeting.

  • Sep 13, 2022

    JOQU-FM FM IWATE Nishizuka introduced OTS-Assay in Iwate Medical University Broadcast Program [https://blog.fmii.co.jp/-inochikara-/]

  • Sep 8, 2022

    Kohei Kume, Ph.D. (Markus Müschen Lab) of Yale University, visited Nishizuka lab.

  • Aug 5, 2022

    Nishizuka gave a talk "Clinical implementation -- somatic mutation as a tumor marker"at 2nd TOLIC Healthtech Device Forum/Healthtech Device Show.

  • Aug 5, 2022

    Abe wins Excellent Award in the Student Research Contest at 2nd TOLIC Healthtech Device Forum/Healthtech Device Show for "Relapse prediction of bladder cancer using diigital PCR mutation monitoring from urine pellet DNA".

  • Jul 31, 2022

    Nishizuka Lab was introduced in Iwate Medical University doctor's association periodicals (No. 135).

  • Jul 22, 2022

    Nishizuka gave a talk "A new monitoring clinical examination for cancer relapse using circulating tumor DNA" as a luncheon seminar sponsored by LSI Medience/Finggal Link at 77th The General Meeting of the Japanese Society of Gastrointestinal Surgery (Yokohama).

  • Jul 16, 2022

    Nishizuka gave a talk "Somatic mutations as tumor marker" as a luncheon seminar sponsored by MSD at 94th Semi-Annual Meeting of the Japanese Society of Pathology Tohoku Niigata (Morioka, Japan).

  • Jul 15, 2022

    Nishizuka gave a talk about how digital PCR will enable our research to Thermo Fisher Scientific Genetic Science Group employees in Asia Pacific Japan region.

  • Jul 7, 2022

    Nishizuka presented a Keynote at Morioka ”metro" city business consortium in Tokyo 2022.http://zaikyomwaio.html.xdomain.jp/Moriokakouiki.html

  • Jun 7, 2022

    New manga "Topic 5, MORIOKA study" is up on Media.

  • Jun 4, 2022

    Our recent research was presented at Gantokai (annual meeting for surgeons).

  • May 12, 2022

    Iwate Nippo introduces the paper by Koizumi et al published in Journal of the National Cancer Institute. See details.

  • Apr 19, 2022

    A paper by Yuka Koizumi has been published in Journal of the National Cancer Institute.

  • Apr 15, 2022

    Crowdfunding is now open for a prospective trial "CHANGE-ES01 study".

  • Apr 5, 2022

    Nishizuka gave a presentation at Japan bio Measurement & Analysis Consortium 145th Ordinary General Meeting. https://www.jmac.or.jp/meeting145/

  • Apr 1, 2022

    Iwate Medical University Hospital starts OTS-Assay. The OTS-Assay uses a patented technology from Nishizuka lab.

  • Mar 22, 2022

    New Nishizuka Lab website released designed by Sooooofa Design Desk, Inc.

  • Feb 25, 2022

    Receives Grand Prize for the 19th Iwate Industry-Academia Collaboration Promotion Council (Liaison-I) sponsored by the Kita-Nippon Bank, Ltd. and the Bank of Iwate, Limited.

    https://news.yahoo.co.jp/articles/8ddc482fcfaebf066449d65a4880d8688725012c

  • Jan 21, 2022

    Dr. Nishizuka had a presentation at 14th Iwate Cancer Forum on Iwate Nippo.